Hyperkalemia associated with use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers (Q37925006)

25 August 2017

1 reference

title

Hyperkalemia associated with use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers (English)

1 reference

25 August 2017

Marsha A Raebel

1

1 reference

25 August 2017

publication date

26 January 2011

1 reference

Cardiovascular Therapeutics

25 August 2017

published in

1 reference

25 August 2017

volume

30

1 reference

25 August 2017

issue

3

1 reference

25 August 2017

page(s)

e156-66

1 reference

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00258.X

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00258.X

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00258.X

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00258.X

Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00258.X

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00258.X

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00258.X

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00258.X

A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00258.X

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00258.X

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00258.X

Incidence and predictors of hyperkalemia in patients with heart failure: an analysis of the CHARM Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00258.X

Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: pathophysiology and indications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00258.X

Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00258.X

Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN). Ramipril Efficacy in Nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00258.X

Efficacy and safety of benazepril for advanced chronic renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00258.X

Adverse effects of enalapril in the Studies of Left Ventricular Dysfunction (SOLVD). SOLVD Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00258.X

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: what to do if the serum creatinine and/or serum potassium concentration rises

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00258.X

Clinical factors associated with hyperkalemia in patients with congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00258.X

The frequency of hyperkalemia and its significance in chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00258.X

21 January 2018

Disorders of potassium

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00258.X

Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone: an analysis of 25 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00258.X

Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00258.X

Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00258.X

Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00258.X

Risk of hyperkalemia in nondiabetic patients with chronic kidney disease receiving antihypertensive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00258.X

Production of renin, angiotensin II, and aldosterone by adrenal explant cultures: response to potassium and converting enzyme inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00258.X

ACE inhibition or angiotensin receptor blockade: impact on potassium in renal failure. VAL-K Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00258.X

Predicting the risk of hyperkalemia in patients with chronic kidney disease starting lisinopril

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00258.X

Renal dysfunction complicating the treatment of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00258.X

Pseudohyperkalemia in serum: a new insight into an old phenomenon

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00258.X

Effects of presentation and electrocardiogram on time to treatment of hyperkalemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00258.X

Hypokalaemia and hyperkalaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00258.X

Hyperkalemia in hospitalized patients: causes, adequacy of treatment, and results of an attempt to improve physician compliance with published therapy guidelines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00258.X

Diabetes and drug-associated hyperkalemia: effect of potassium monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00258.X

Drug-induced hyperkalemia: old culprits and new offenders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00258.X

Hyperkalemia in Outpatients Using Angiotensin-Converting Enzyme Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00258.X

Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure: results from the ATLAS trial. The Assessment of Treatment with Lisinopril and Survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00258.X

Increasingly restrictive definitions of hyperkalemia outcomes in a database study: effect on incidence estimates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00258.X

Diabetes may be independent risk factor for hyperkalaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00258.X

Hyperkalaemia in diabetes: prevalence and associations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00258.X

Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00258.X

Laboratory safety monitoring of chronic medications in ambulatory care settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00258.X

Laboratory monitoring of drugs at initiation of therapy in ambulatory care

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00258.X

Laboratory monitoring of potassium and creatinine in ambulatory patients receiving angiotensin converting enzyme inhibitors and angiotensin receptor blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00258.X

Improving laboratory monitoring at initiation of drug therapy in ambulatory care: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00258.X

Quality indicators for appropriate medication use in vulnerable elders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00258.X

Hyperkalemia and hyporeninemic hypoaldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00258.X

Noni juice (Morinda citrifolia): hidden potential for hyperkalemia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00258.X

Trimethoprim-sulfamethoxazole-induced hyperkalemia in patients receiving inhibitors of the renin-angiotensin system: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00258.X

A mechanism for pentamidine-induced hyperkalemia: inhibition of distal nephron sodium transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00258.X

Drug-drug interactions among elderly patients hospitalized for drug toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00258.X

Rapid Life-Threatening Hyperkalemia After Addition of Amiloride HC1/Hydrochlorothiazide to Angiotensin-Converting Enzyme Inhibitor Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00258.X

Labetalol-induced hyperkalemia in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00258.X

Attenuation of Angiotensin II- and III-induced Aldosterone Release by Prostaglandin Synthesis Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00258.X

Syncope caused by nonsteroidal anti-inflammatory drugs and angiotensin-converting enzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00258.X

Heparin-induced aldosterone suppression and hyperkalemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00258.X

Variations of serum potassium level and risk of hyperkalemia in inpatients receiving low-molecular-weight heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00258.X

Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00258.X

Indications for Hospitalization of Patients With Hyperkalemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00258.X

ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00258.X

10.1111/J.1755-5922.2010.00258.X

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference